Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables

BACKGROUND: The prevalence of type 2 diabetes mellitus (T2DM) is increasing rapidly among Chinese adults, and limited data are available on T2DM management and the status of glycemic control in China. We assessed the efficacy of oral antidiabetes drugs (OADs), glucagon-like peptide-1 (GLP-1) recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Li-Nong, Lu, Ju-Ming, Guo, Xiao-Hui, Yang, Wen-Ying, Weng, Jian-Ping, Jia, Wei-Ping, Zou, Da-Jin, Zhou, Zhi-Guang, Yu, De-Min, Liu, Jie, Shan, Zhong-Yan, Yang, Yu-Zhi, Hu, Ren-Ming, Zhu, Da-Long, Yang, Li-Yong, Chen, Li, Zhao, Zhi-Gang, Li, Qi-Fu, Tian, Hao-Ming, Ji, Qiu-He, Liu, Jing, Ge, Jia-Pu, Shi, Li-Xin, Xu, Yan-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729491/
https://www.ncbi.nlm.nih.gov/pubmed/23800082
http://dx.doi.org/10.1186/1471-2458-13-602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729491/
https://www.ncbi.nlm.nih.gov/pubmed/23800082
http://dx.doi.org/10.1186/1471-2458-13-602

Ejemplares similares